Objective To evaluate the clinical efficacy and safety of Ganjie Bingmei Tablet(甘桔冰梅片,GBT)in treating acute pharyngitis with wind-heat invading the lung syndrome.Methods Using multi-center,rando-mized,double-blind,double-dummy,positive and parallel controlled clinical trial design,144 acute pharyngitis patients with wind-heat invading the lung syndrome from October 8th,2022 to March 31st,2023 were collected and randomly assigned to the treatment group and the control group,with 72 cases in each group.The treatment group was treated by GBT(0.4 g each time,4 times a day)combined with Ganjie Qingyan Granules(甘桔清咽颗粒,GQG)pla-cebo(10 g each time,3 times a day),while the control group was treated by GQG(10 g each time,3 times a day)combined with GBT placebo(0.4 g each time,4 times a day),both for 5 days.The clinical efficacy of the two groups was observed,and the disappearance rate of pharyngalgia and the efficacy regarding TCM syndromes were compared between groups after treatment.The visual analog scale(VAS)score before and after treatment was assessed,and the safety was evaluated.Results The disappearance rate of pharyngalgia in the treatment group was 98.61％(71/72),significantly higher than 80.56％(58/72)in the control group(P＜0.01).The VAS scores in both groups significantly decreased after treatment(P＜0.05),and lower score was found in the treatment group than the control group(P＜0.05).The total effective rate regarding TCM syndromes was 100％in both groups,but the curative rate was signifi-cantly higher in the treatment group(73.61％,53/72)than the control group(62.50％,45/72,P＜0.05).There were no obvious adverse reactions in the both groups.Conclusion GBT is effective and safe in treating acute pharyngitis with wind-heat affecting the lung syndrome.
acute pharyngitiswind-heat invading the lung syndromesore throatGanjiebingmei Tablet(甘桔冰梅片)randomized controlled trial
NETL
NSTL
万方数据
